Earth Science Tech Reports 94% Revenue Growth Amid Rising Expenses and Strategic Expansions

Earth Science Tech, Inc. (PINK: ETST) has recently reported its financials for the three and nine months ended December 31, 2024, revealing significant changes in its income statement and operational strategy.

Key Highlights:

• Revenue Growth: Revenue increased to $7.35 million for Q3 2024, up from $3.79 million in Q3 2023, representing an impressive 94% year-over-year growth.
• Gross Profit: Gross profit reached $5.09 million, compared to $2.38 million in the previous year, reflecting a higher gross margin of 69% versus 63%.
• Net Income: The company reported a net income of $206,411, a decrease from $225,443 year-over-year.
• Total Assets: As of December 31, 2024, total assets rose to $5.71 million, significantly up from $3.88 million at the end of the previous fiscal year.
• Cash Position: Cash and cash equivalents decreased to $522,239 from $697,721, driven by investing activities.
• Expenses Surge: Total expenses reached $4.86 million, up from $2.15 million due to an increase in labor costs, which spiked significantly to $3.30 million.

Positive Aspects:

• Strong revenue growth indicates effective market penetration and successful sales strategies.
• Notable increase in gross profit highlights improved operational efficiency.
• Solid asset growth enhances the company's financial stability.

Negative Aspects:

• Net income saw a slight decrease, which may concern investors about profit sustainability amidst rising expenses.
• The significant jump in labor costs denotes rapid expansion but also raises concerns about long-term sustainability.
• Cash reserves decreased due to heavy investing activities, indicating the need for careful capital management.

Strategic Outlook:

Earth Science Tech, Inc. is actively expanding its operational footprint through acquisitions, such as **Mister Meds** and **Avenvi**, aiming to enhance its market presence in both pharmaceutical and real estate sectors. The company is also focusing on telemedicine growth and improving its compounding pharmacy capabilities.

In summary, while Earth Science Tech, Inc. shows promising revenue growth and a strong operational strategy, it must navigate rising expenses and maintain profitability to ensure long-term success.